The initial year-on-year increase in overall supply reported by others[17, 24] appears to have stabilised 4 years post-reclassification while having little impact on prescription items over the entire study period. Despite a temporal relationship between OTC Doramapimod manufacturer ophthalmic chloramphenicol supply and items dispensed on prescription the appropriateness of supplies from community pharmacies remains
unknown. The benefits and risks of having ophthalmic chloramphenicol available OTC and the impact of updated practice guidance on its prescribing OTC need to be studied further to better understand its current, high level of use. The Author(s) declare(s) that they have no conflicts of interest to disclose. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. We are thankful to IMS Health for supplying the pharmacy BIBF 1120 datasheet wholesale data and we are also grateful to Dr Karen Hodson (Cardiff University) for critiquing the draft paper and providing helpful comments. Some data were presented at the 40th European Symposium of Clinical Pharmacy in Dublin on 19 October 2011.
Abstract one: Supply of ophthalmic chloramphenicol in primary care in Wales 5 years after reclassification to over-the-counter availability. Abstract two: Investigation of a correlation between over-the-counter sales and primary care prescriptions for chloramphenicol eye drops. All authors had complete access to the study data that support the publication. HD conceived the study, participated in its design, performed the statistical analysis and drafted the manuscript. DNJ participated in the design of the study and helped to draft the manuscript.
RW conceived the study, acquired data and helped to draft the manuscript. “
“Objective The aim of the study was to explore, in the Malaysian general population: knowledge and beliefs of the characteristics in general of medication-related side effects and side effects associated with different types of medicines; behaviour related to the safe use of drugs before and after taking a medication; and behaviour in the event of a medication-related side effect. Methods A 24-item self-administered questionnaire was developed and used to survey the general public living or working Molecular motor in suburban Kuala Lumpur, Malaysia. Eight hundred questionnaires were distributed, face to face, by researchers using quota sampling. Respondents’ knowledge, belief and behaviour were analysed and correlated with demographics, medical history and experience of side effects. Key findings Six hundred and ten respondents completed the questionnaire giving a response rate of 76.3%. The mean knowledge score for the respondents was 18.4 ± 3.6 out of the maximum possible score of 26. Educational level and experience of side effect had an influence on the knowledge score obtained.